Neal Bhatia, MD stopped by the Dermcast studios during the SDPA’s Annual Summer Dermatology Conference 2018, held in Seattle, Washington, to discuss actinic keratosis and the best modalities of treatment currently available.
Actinic keratosis (AKs) is one of the most common diagnoses patients receive from the dermatologist, and the medical cost to treat AKs is close to 2 billion dollars annually. AKs are treated with destructive procedures, such as cryotherapy, curettage, electrocautery, and chemical peels, to prevent malignant transformation, relieve patient symptoms, and improve quality of life …